Informatie:
Fout:
ID
14151
Beschrijving
Longitudinal Assessment of Adults With Severe Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT01976767
Link
https://clinicaltrials.gov/show/NCT01976767
Trefwoorden
Versies (1)
- 01-04-16 01-04-16 -
Geüploaded op
1 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Asthma NCT01976767
Eligibility Asthma NCT01976767
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT01976767
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Informed consent | Compliance behavior
Item
1. able to give written informed consent prior to participation in the study, which includes ability to comply with the requirements and restrictions listed in the consent form. informed consent must be obtained prior to undertaking any study procedures.
boolean
C0021430 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2])
C0085732 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2])
Age | Gender
Item
2. male or female subject aged 18 years or older at screening.
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
Compliance behavior | Ability
Item
3. able to complete the study and all measurements.
boolean
C1321605 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,2])
Able to read | Comprehension | Able to write | Compliance behavior
Item
4. able to read, comprehend, and write at a sufficient level to complete study related materials.
boolean
C0586740 (UMLS CUI [1])
C0162340 (UMLS CUI [2])
C0584993 (UMLS CUI [3])
C1321605 (UMLS CUI [4])
C0162340 (UMLS CUI [2])
C0584993 (UMLS CUI [3])
C1321605 (UMLS CUI [4])
Study Subject Participation Status
Item
5. subjects will be allowed to enrol in other studies while taking part on this study. however, permission from the scientific board must be obtained to enrol or allow the continued participation of a subject enrolled in another study.
boolean
C2348568 (UMLS CUI [1])
Exclusion
Item
general exclusion criteria:
boolean
C2828389 (UMLS CUI [1])
Study Subject Participation Status | Medically unfit
Item
1. as a result of medical interview, physical examination or screening investigation the physician responsible considers the subject unfit for the study either because of the risk to the subject due to the study or the influence this may have on the study results.
boolean
C2348568 (UMLS CUI [1])
C3841806 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C3841806 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
recreational drug use | Other allergy
Item
2. the subject has a history of recreational drug use or other allergy, which, in the opinion of the responsible physician, contra-indicates their participation.
boolean
C1318616 (UMLS CUI [1])
C2886714 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
C2886714 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
3. subject is female who is pregnant or lactating or up to 6 weeks post partum or 6 weeks cessation of breast feeding. if a woman is subsequently found to have been pregnant at the time of an assessment data from that assessment will not be included in the analyses.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0086839 (UMLS CUI [3])
C0420983 (UMLS CUI [4])
C0006147 (UMLS CUI [2])
C0086839 (UMLS CUI [3])
C0420983 (UMLS CUI [4])
Study Subject Participation Status | invasive medical procedure
Item
4. the subject has participated within 3 months of the first dose in a study using a new molecular entity, or the first dose in any other study investigating drugs or having participated within three months in a study with invasive procedures. any u-biopred assessments should be deferred until 3 months after the first dose or invasive procedure. permission from the scientific board must be obtained to enroll or allow the continued participation of a subject enrolled in another study.
boolean
C2348568 (UMLS CUI [1])
C0199173 (UMLS CUI [2])
C0199173 (UMLS CUI [2])
Patient Non-Compliance | Risk Assessment
Item
5. those who, in the opinion of the investigator, have a risk of non-compliance with study procedures.
boolean
C0376405 (UMLS CUI [1,1])
C0086930 (UMLS CUI [1,2])
C0086930 (UMLS CUI [1,2])
Mental disorders
Item
6. the subject has a recent history of incapacitating psychiatric disorders
boolean
C0004936 (UMLS CUI [1])
Upper Respiratory Infections | Lower respiratory tract infection | Common Cold
Item
7. history or current evidence of an upper or lower respiratory infection or symptoms (including common cold) within 2 weeks of baseline assessments (assessments should be deferred).
boolean
C0041912 (UMLS CUI [1])
C0149725 (UMLS CUI [2])
C0009443 (UMLS CUI [3])
C0149725 (UMLS CUI [2])
C0009443 (UMLS CUI [3])